ESMO Congress 2024
Review presentation schedules, news releases, and research summaries presented by Dana-Farber physician-scientists at ESMO Congress 2024 in Barcelona, Spain from September 13 - September 17.
News Releases:
- Ann Partridge Receives 2024 ESMO Award for Significant Contributions to Breast Cancer Research and Patient Care
- Comprehensive Cancer Research from Dana-Farber to Lead ESMO Congress 2024
- Breast Cancer Research: New Studies Show How Post-Treatment Lifestyle Choices Shape Long-Term Outcomes After Diagnosis
- Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer
Resources:
Research Summaries:
- Repeat Immune Checkpoint Inhibitor Therapy not Recommended for Advanced Kidney Cancer
- High-Dose Vitamin D3 Does Not Provide Benefit for Metastatic Colorectal Cancer
Prostate Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ESMO 2024.
Bladder Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from ESMO 2024.
Kidney Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2024.